# Pharmasol Corporation – FDA Inspection, Aug 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/pharmasol-corporation/cbed2c53-5e85-4e38-948e-30bde579e8c3
Source feed: FDA_Inspections

> FDA inspection 1062647 of Pharmasol Corporation, August 20, 2018. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR parts 211 and 820. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062647
- Company Name: Pharmasol Corporation
- Inspection Date: 2018-08-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 9

## Related Documents

- [FDA Inspection 1143828 - 2021-06-14](https://www.keypedia.com/records/fda_inspections/pharmasol-corporation/a3af7ea1-988d-4a7b-a001-a2260d559027)
- FDA Inspection 982568 - 2016-08-04
- FDA Inspection 936866 - 2015-07-16
- FDA Inspection 902345 - 2014-10-30
- [FDA Inspection 853366 - 2013-10-30](https://www.keypedia.com/records/fda_inspections/pharmasol-corporation/9422a863-d626-47eb-ba0c-5a880e1e05f1)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jonathan-g-matrisciano/17e5bce2-75a6-4182-925d-b94b42763dd2)
- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/pharmasol-corporation/7961d42d-8409-45eb-8448-c0f2729ef17c

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144